Ranking multiple interventions is a crucial task in network meta-analysis (NMA) to guide clinical and policy decisions. However, conventional ranking methods often oversimplify treatment distinctions, potentially yielding misleading conclusions due to inherent uncertainty in relative intervention effects. To address these limitations, we propose a novel Bayesian rank-clustering estimation approach, termed rank-clustering estimation (RaCE), specifically developed for NMA. Rather than identifying a single “best” intervention, RaCE enables the probabilistic clustering of interventions with similar effectiveness, offering a more nuanced and parsimonious interpretation. By decoupling the clustering procedure from the NMA modeling process, RaCE is a flexible and broadly applicable approach that can accommodate different types of outcomes (binary, continuous, and survival), modeling approaches (arm-based and contrast-based), and estimation frameworks (frequentist or Bayesian). Simulation studies demonstrate that RaCE effectively captures rank-clusters even under conditions of substantial uncertainty and overlapping intervention effects, providing more reasonable result interpretation than traditional single-ranking methods. We illustrate the practical utility of RaCE through an NMA application to frontline immunochemotherapies for follicular lymphoma, revealing clinically relevant clusters among treatments previously assumed to have distinct ranks. Overall, RaCE provides a valuable tool for researchers to enhance rank estimation and interpretability, facilitating evidence-based decision-making in complex intervention landscapes.